NO995940L - Use of leptin antagonists for the treatment of diabetes - Google Patents

Use of leptin antagonists for the treatment of diabetes

Info

Publication number
NO995940L
NO995940L NO995940A NO995940A NO995940L NO 995940 L NO995940 L NO 995940L NO 995940 A NO995940 A NO 995940A NO 995940 A NO995940 A NO 995940A NO 995940 L NO995940 L NO 995940L
Authority
NO
Norway
Prior art keywords
treatment
diabetes
leptin antagonists
leptin
antagonists
Prior art date
Application number
NO995940A
Other languages
Norwegian (no)
Other versions
NO995940D0 (en
Inventor
Michael Cawthorne
Valur Emilsson
Yong-Ling Liu
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP1997/002240 external-priority patent/WO1998055139A1/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Priority to NO995940A priority Critical patent/NO995940L/en
Publication of NO995940D0 publication Critical patent/NO995940D0/en
Publication of NO995940L publication Critical patent/NO995940L/en

Links

Abstract

Anvendelse av en leptin-antagonist for fremstilling av et medikament for behandling av lidelser som er et resultat av svikt i insulinsekresjon, hyperglykemi og insulinresistens.Use of a leptin antagonist for the manufacture of a medicament for the treatment of disorders resulting from failure in insulin secretion, hyperglycemia and insulin resistance.

NO995940A 1997-06-06 1999-12-03 Use of leptin antagonists for the treatment of diabetes NO995940L (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO995940A NO995940L (en) 1997-06-06 1999-12-03 Use of leptin antagonists for the treatment of diabetes

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/EP1997/002240 WO1998055139A1 (en) 1997-06-06 1997-06-06 Use of leptin antagonists for the treatment of diabetes
NO995940A NO995940L (en) 1997-06-06 1999-12-03 Use of leptin antagonists for the treatment of diabetes

Publications (2)

Publication Number Publication Date
NO995940D0 NO995940D0 (en) 1999-12-03
NO995940L true NO995940L (en) 2000-02-03

Family

ID=19904053

Family Applications (1)

Application Number Title Priority Date Filing Date
NO995940A NO995940L (en) 1997-06-06 1999-12-03 Use of leptin antagonists for the treatment of diabetes

Country Status (1)

Country Link
NO (1) NO995940L (en)

Also Published As

Publication number Publication date
NO995940D0 (en) 1999-12-03

Similar Documents

Publication Publication Date Title
TR199902980T2 (en) Use of leptin antagonists for the treatment of diabetes.
NO2010012I1 (en) Exenatide (Exenatide)
EA200101156A1 (en) DRUG COMPOSITIONS OF A NEW TYPE ON THE BASIS OF POSSESSING HOLYNTHERGIC ACTION OF COMPOUNDS AND β-MIMETIC
UA83854C2 (en) Use of telmisartan in order to increase insulin sensitivity
AR022368A1 (en) PROCEDURE FOR MANAGING INSULINOTROPIC PEPTIDES
WO2003018516A3 (en) Glucagon-like peptide-1 analogs
EA200000747A1 (en) METHOD OF ADMINISTRATION OF ASPB28-INSULIN PERSON
CO5011096A1 (en) MEDICINES CONTAINING ANTAGONISTS OF THE 5-HT3 RECEPTOR FOR THE TREATMENT OF IBS
AR008444A1 (en) EMPLOYMENT OF LEPTINE ANTAGONISTS FOR THE TREATMENT OF INSULIN RESISTANCE IN TYPE II DIABETES
BR0312947A (en) therapies for renal failure using interferon-beta
WO2004050115A3 (en) Combination treatment using exendin-4 and thiazolidinediones
WO2003062273A3 (en) Modulator of the notch signalling pathway and use thereof in medical treatment
NO992062L (en) Preparation for the treatment of asthma, containing loratadine and a decongestant
NO994165L (en) Use of descarboethoxyloratadine for the manufacture of a medicament for the treatment of urinary incontinence, travel sickness and dizziness
ATE318607T1 (en) OPHTHALMIC CONTAINING HEPARIN
WO2001026651A3 (en) Selective estrogen receptor modulators in the treatment or reduction of the risk of acquiring hypertension, cardiovascular diseases, and insulin resistance
AU2003252182A1 (en) Therapeutic treatment for the metabolic syndrome and type 2 diabetes
DK0981347T3 (en) The use of levobupivacaine in facial surgery
EE200100553A (en) Use of saredutant and pharmaceutically acceptable salts thereof for the manufacture of a medicament for the treatment or prevention of mood disorders, adaptive disorders, or mixed anxiety depressive disorders.
NO995940L (en) Use of leptin antagonists for the treatment of diabetes
TR200302008T4 (en) Use of beta-adrenoceptor antagonists in the manufacture of a medicament for the treatment of external retinal disorders.
WO1999053064A3 (en) Methods of delivering glp-1
EA200401454A1 (en) NEW COMBINATION FROM REVERSIBLE ACTING PROTONE PUMP INHIBITORS AND USED IN THE THERAPY OF RESPIRATORY WAYS OF MEDICINAL SUBSTANCES FOR THE TREATMENT OF RESPIRATORY DISEASES
AR006871A1 (en) USE OF A LEPTIN ANTAGONIST IN THE MANUFACTURE OF A MEDICINAL PRODUCT
BR9714726A (en) Use of leptin antagonists in the treatment of diabetes

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application